Connect with us

Hi, what are you looking for?

Saturday, Jul 24, 2021
Mugglehead Magazine
Cannabis & psychedelics industry news based in Vancouver, B.C.
  • Loading stock data...

Industry update

Valens enters US CBD market with purchase of Florida firm

The Canadian pot product company says its Green Roads deal represents only the first step in its US expansion strategy

Valens to enter US market with purchase of Florida CBD firm
Valens to enter US market with purchase of Florida CBD firm

The Valens Co. (TSX: VLNS) (OTCQX: VLNCF) is buying a Florida-based CBD producer as the Canadian pot product manufacturer’s first foray into the United States.

On Tuesday, the British Columbia-based company said it will acquire Green Roads for US$40 million in cash and stock, plus US$20 million if earnings-based targets are met.

Green Roads is the largest private company in the U.S. that sells non-psychoactive CBD online and in 7,000 retail locations.

Valens says the combined entity would have had sales of $111.6 million in 2020. Valens reported fiscal 2020 net revenue of $83.8 million.

The deal gives it immediate entry into U.S. CBD, and the company says it provides a potential pathway to enter the country’s legal weed market.

While THC products remain illegal at the federal level, there’s speculation that laws will be eased with Democrats in power. Currently, 18 states have legalized recreational cannabis.

“The acquisition of Green Roads represents only the first step in our U.S. expansion strategy,” Valens CEO Tyler Robson said in a statement. “We expect to continue to unlock complementary, revenue-generating opportunities while we forge our presence and build our reputation in the world’s largest cannabinoid market.”

Valens to enter US market with purchase of Florida CBD firm

Photo via Green Roads

The transaction is expected to be accretive to 2021 earnings, Valens says. The Green Roads brand ranked second by market share in the U.S. CBD market in the third quarter last year, according to Brightfield Group.

Green Roads produces CBD oils, topicals, edibles and pet products at its Current Good Manufacturing Practice-approved facilities.

Cannabidiol sales in the U.S. reached a record $6 billion (US$4.7 billion) last year, Brightfield estimates.

The deal comes amid a wave of consolidation in the cannabis sector as Canadian companies struggle in a highly competitive market slammed with supply gluts.

As sales continue to miss projections, Canadian operators have been seeking access to the larger U.S. market.

Mega-producer Canopy Growth Corp. (TSX: WEED) (Nasdaq: CGC) has signed a deal to merge with Acreage Holdings, Inc. (CSE: ACRG.U) that’s contingent upon the U.S. government legalizing cannabis sales.

And last year rival Aphria Inc. (TSX: APHA) (Nasdaq: APHA) bought U.S. beer company SweetWater Brewing.

After Valens posted record revenue of $31.9 million in first-quarter 2020, an oversupply of bulk resin caused a major slowdown in the extraction market.

The company has since pivoted to a manufacturing strategy in Canada, and has previously stated it intends to expand into the U.S. and international markets.

The Green Roads deal has been approved by Valens’s board of directors and is expected to close in June pending regulatory approval.

Shares of Valens rose 4.6 per cent Tuesday to $3.43 on the Toronto Stock Exchange.

Top image via Green Roads

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Jared Gnam on Twitter

jared@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Canada

As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices

Enforcement

The legislation's steep penalties and confusing rules are a step backward to populations that have used cannabis traditionally for centuries

News

Cannabis will be treated like alcohol under the company's policy changes